Forks in the road: Definitions of response, remission, recovery, and other dichotomized outcomes in randomized controlled trials for adolescent depression. A scoping review.
adolescent
antidepressants
child/adolescent
clinical trials
depression
empirical supported treatments
evidence-based medicine
humans
measurement/psychometrics
outcome assessment (health care)
randomized controlled trials as topic
treatment
treatment resistance
Journal
Depression and anxiety
ISSN: 1520-6394
Titre abrégé: Depress Anxiety
Pays: United States
ID NLM: 9708816
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
revised:
18
06
2021
received:
23
10
2020
accepted:
24
06
2021
pubmed:
28
7
2021
medline:
8
3
2022
entrez:
27
7
2021
Statut:
ppublish
Résumé
Definitions of dichotomous outcome terms, such as "response," "remission," and "recovery" are central to the design, interpretation, and clinical application of randomized controlled trials of adolescent depression interventions. Accordingly, this scoping review was conducted to document how these terms have been defined and justified in clinical trials. Bibliographic databases MEDLINE, Embase, APA PsycInfo, and CINAHL were searched from inception to February 2020 for randomized controlled trials evaluating treatments for adolescent depression. Ninety-eight trials were included for data extraction and analysis. Assessment of outcome measurement instruments, metric strategies, methods of aggregation, and measurement timing, yielded 53 unique outcome definitions of "response" across 45 trials that assessed response, 47 unique definitions of "remission" in 29 trials that assessed remission, and 19 unique definitions of "recovery" across 11 trials that assessed recovery. A minority of trials (N = 35) provided a rationale for dichotomous outcomes definitions, often by citing other studies that used a similar definition (N = 11). No rationale included input from youth or families with lived experience. Our review revealed that definitions of "response," "remission," "recovery," and related terms are highly variable, lack clear rationales, and are not informed by key stakeholder input. These limitations impair pooling of trial results and the incorporation of trial findings into pragmatic treatment decisions in clinical practice. Systematic approaches to establishing outcome definitions are needed to enhance the impact of trials examining adolescent depression treatment.
Sections du résumé
BACKGROUND
Definitions of dichotomous outcome terms, such as "response," "remission," and "recovery" are central to the design, interpretation, and clinical application of randomized controlled trials of adolescent depression interventions. Accordingly, this scoping review was conducted to document how these terms have been defined and justified in clinical trials.
METHOD
Bibliographic databases MEDLINE, Embase, APA PsycInfo, and CINAHL were searched from inception to February 2020 for randomized controlled trials evaluating treatments for adolescent depression. Ninety-eight trials were included for data extraction and analysis.
RESULTS
Assessment of outcome measurement instruments, metric strategies, methods of aggregation, and measurement timing, yielded 53 unique outcome definitions of "response" across 45 trials that assessed response, 47 unique definitions of "remission" in 29 trials that assessed remission, and 19 unique definitions of "recovery" across 11 trials that assessed recovery. A minority of trials (N = 35) provided a rationale for dichotomous outcomes definitions, often by citing other studies that used a similar definition (N = 11). No rationale included input from youth or families with lived experience.
CONCLUSION
Our review revealed that definitions of "response," "remission," "recovery," and related terms are highly variable, lack clear rationales, and are not informed by key stakeholder input. These limitations impair pooling of trial results and the incorporation of trial findings into pragmatic treatment decisions in clinical practice. Systematic approaches to establishing outcome definitions are needed to enhance the impact of trials examining adolescent depression treatment.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1152-1168Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Atkinson, S., Lubaczewski, S., Ramaker, S., England, R. D., Wajsbrot, D. B., Abbas, R., & Findling, R. L. (2018). Desvenlafaxine versus placebo in the treatment of children and adolescents with major depressive disorder. Journal of Child and Adolescent Psychopharmacology, 28(1), 55-65. https://doi.org/10.1089/cap.2017.0099
Atkinson, S. D., Prakash, A., Zhang, Q., Pangallo, B. A., Bangs, M. E., Emslie, G. J., & March, J. S. (2014). A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder. Journal of Child and Adolescent Psychopharmacology, 24(4), 180-189. https://doi.org/10.1089/cap.2013.0146
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub.
Bangs, M. E., Emslie, G. J., Spencer, T. J., Ramsey, J. L., Carlson, C., Bartky, E. J., & Sumner, C. R. (2007). Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. Journal of Child and Adolescent Psychopharmacology, 17(4), 407-419. https://doi.org/10.1089/cap.2007.0066
Berard, R., Fong, R., Carpenter, D. J., Thomason, C., & Wilkinson, C. (2006). An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder. Journal of Child and Adolescent Psychopharmacology, 16(1-2), 59-75. https://doi.org/10.1089/cap.2006.16.59
Bernal, G., Rivera-Medina, C. L., Cumba-Aviles, E., Reyes-Rodriguez, M. L., Saez-Santiago, E., Duarte-Velez, Y., & Rossello, J. (2019). Can cognitive-behavioral therapy be optimized with parent psychoeducation? A randomized effectiveness trial of adolescents with major depression in puerto rico. Family Process, 58(4), 832-854. https://doi.org/10.1111/famp.12455
Birmaher, B., & Brent, D. (2007). Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 46(11), 1503-1526. https://doi.org/10.1097/chi.0b013e318145ae1c
Bogen, S., Legenbauer, T., Gest, S., & Holtmann, M. (2016). Lighting the mood of depressed youth: Feasibility and efficacy of a 2 week-placebo controlled bright light treatment for juvenile inpatients. Journal of Affective Disorders, 190, 450-456. https://doi.org/10.1016/j.jad.2015.09.026
Bolton, P., Bass, J., Betancourt, T., Speelman, L., Onyango, G., Kathleen, F. C., Neugebauer, R., Laura Murray, L., Verdeli, & H. (2007). Interventions for depression symptoms among adolescent survivors of war and displacement in northern Uganda: A randomized controlled trial. JAMA: Journal of the American Medical Association, 298, 519-527.
Boulos, C., Kutcher, S., Marton, P., Simeon, J., Ferguson, B., & Roberts, N. (1991). Response to desipramine treatment in adolescent major depression. Psychopharmacology Bulletin, 27(1), 59-65.
Braconnier, A., Le Coent, R., & Cohen, D. (2003). Paroxetine versus clomipramine in adolescents with severe major depression: A double-blind, randomized, multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 42(1), 22-29. https://doi.org/10.1097/00004583-200301000-00007
Brent, D. A., Holder, D., Kolko, D., Birmaher, B., Baugher, M., Roth, C., Iyengar, S., & Johnson, B. A. (1997). A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Archives of General Psychiatry, 54(9), 877-885.
Brent, D., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M., & Zelazny, J. (2008). Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. Journal of the American Medical Association, 299(8), 901-913. https://doi.org/10.1001/jama.299.8.901
Butcher, N. J., Mew, E. J., Monsour, A., Chan, A. W., Moher, D., & Offringa, M. (2020). Outcome reporting recommendations for clinical trial protocols and reports: a scoping review. Trials, 21(1), 1-17.
Chambers, W. J., Puig-Antich, J., Hirsch, M., Paez, P., Ambrosini, P. J., Tabrizi, M. A., & Davies, M. (1985). The assessment of affective disorders in children and adolescents by semistructured interview: Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children. Archives of General Psychiatry, 42(7), 696-702. https://doi.org/10.1001/archpsyc.1985.01790300064008
Clarke, G., DeBar, L., Lynch, F., Powell, J., Gale, J., O'Connor, E., & Hertert, S. (2005). A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. Journal of the American Academy of Child and Adolescent Psychiatry, 44(9), 888-898. https://doi.org/10.1097/01.chi.0000171904.23947.54
Clarke, G., DeBar, L. L., Pearson, J. A., Dickerson, J. F., Lynch, F. L., Gullion, C. M., & Leo, M. C. (2016). Cognitive behavioral therapy in primary care for youth declining antidepressants: A randomized trial. Pediatrics, 137(5). https://doi.org/10.1542/peds.2015-1851
Clarke, G., McGlinchey, E. L., Hein, K., Gullion, C. M., Dickerson, J. F., Leo, M. C., & Harvey, A. G. (2015). Cognitive-behavioral treatment of insomnia and depression inadolescents: A pilot randomized tria. Behaviour Research and Therapy, 69, 111-118. https://doi.org/10.1016/j.brat.2015.04.009
Clarke, G. N., Rohde, P., Lewinsohn, P. M., Hops, H., & Seeley, J. R. (1999). Cognitive-behavioral treatment of adolescent depression: Efficacy of acute group treatment and booster sessions. Journal of the American Academy of Child and Adolescent Psychiatry, 38(3), 272-279. https://doi.org/10.1097/00004583-199903000-00014
Cook, J. A., Julious, S. A., Sones, W., Hampson, L. V., Hewitt, C., Berlin, J. A., & Vale, L. D. (2018). DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial. bmj, 363. https://www.bmj.com/content/363/bmj.k3750
Coulter, A. (2017). Measuring what matters to patients. BMJ, 356, j816. https://doi.org/10.1136/bmj.j816
Courtney, D. B., Bennett, K., & Szatmari, P. (2019). The forest and the trees: Evidence-based medicine in the age of information. Journal of the American Child and Adolescent Psychtriatry, 58(1), 8-15. https://doi.org/10.1016/j.jaac.2018.06.035
Courtney, D. B., Watson, P., Chan, B. W. C., Bennett, K. J., Neprily, K., Zentner, T., & Szatmari, P. (2020). How have predictors, moderators, mediators, treatment response, remission and resistance been defined and measured in randomised controlled trials for adolescent depression? A scoping review protocol. BMJ Open, 10(6), 036171. https://doi.org/10.1136/bmjopen-2019-036171
Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Retrieved from www.covidence.org
Darnay, K., Hawke, L. D., Chaim, G., & Henderson, J., The INNOVATE Research Team. (2019). INNOVATE research: Youth engagement guidebook for researchers. Centre for Addiction and Mental Health.
Davey, C. G., Chanen, A. M., Hetrick, S. E., Cotton, S. M., Ratheesh, A., Amminger, G. P. G. P., Koutsogiannis, J., Phelan, M., Mullen, E., Harrison, B. J., Rice, S., Parker, A. G., Dean, O. M., Weller, A., Kerr, M., Quinn, A. L., Catania, L., Kazantzis, N., McGorry, P. D., & Berk, M. (2019). The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial. The Lancet Psychiatry, 6(9), 735-744. https://doi.org/10.1016/s2215-0366(19)30215-9
Deas, D., Randall, C. L., Roberts, J. S., & Anton, R. F. (2000). A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: A pilot study. Human Psychopharmacology: Clinical and Experimental, 15(6), 461-469. https://doi.org/10.1002/1099-1077
DelBello, M. P., Hochadel, T. J., Portland, K. B., Azzaro, A. J., Katic, A., Khan, A., & Emslie, G. (2014). A double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescents. Journal of Child and Adolescent Psychopharmacology, 24(6), 311-317. https://doi.org/10.1089/cap.2013.0138
Diamond, G. S., Kobak, R. R., Krauthamer Ewing, E. S., Levy, S. A., Herres, J. L., Russon, J. M., & Gallop, R. J. (2019). A randomized controlled trial: Attachment-based family and nondirective supportive treatments for youth who are suicidal. Journal of the American Academy of Child and Adolescent Psychiatry, 58(7), 721-731. https://doi.org/10.1016/j.jaac.2018.10.006
Diamond, G. S., Wintersteen, M. B., Brown, G. K., Diamond, G. M., Gallop, R., Shelef, K., & Levy, S. (2010). Attachment-based family therapy for adolescents with suicidal ideation: A randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 49(2), 122-131. https://doi.org/10.1097/00004583-201002000-00006
Durgam, S., Chen, C., Migliore, R., Prakash, C., Edwards, J., & Findling, R. L. (2018). A phase 3, double-blind, randomized, placebo-controlled study of vilazodone in adolescents with major depressive disorder. Paediatric Drugs, 20(4), 353-363. https://doi.org/10.1007/s40272-018-0290-4
Dwyer, J. B., Stringaris, A., Brent, D. A., & Bloch, M. H. (2020). Annual research review: defining and treating pediatric treatment-resistant depression. Journal of Child Psychology and Psychiatry and Allied Disciplines, 61(3), 312-332. https://doi.org/10.1111/jcpp.13202
Emslie, G. J., Findling, R. L., Yeung, P. P., Kunz, N. R., & Li, Y. (2007). Venlafaxine ER for the treatment of pediatric subjects with depression: Results of two placebo-controlled trials. Journal of the American Academy of Child and Adolescent Psychiatry, 46(4), 479-488. https://doi.org/10.1097/chi.0b013e31802f5f03
Emslie, G. J., Heiligenstein, J. H., Wagner, K. D., Hoog, S. L., Ernest, D. E., Brown, E., & Jacobson, J. G. (2002). Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled: Randomized clinical trial. Journal of American Academy of Child and Adolescent Psychiatry, 41(10), 1205-1215. https://doi.org/10.1097/00004583-200210000-00010
Emslie, G. J., Prakash, A., Zhang, Q., Pangallo, B. A., Bangs, M. E., & March, J. S. (2014). A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder. Journal of Child and Adolescent Psychopharmacology, 24(4), 170-179. https://doi.org/10.1089/cap.2013.0096
Emslie, G. J., Rush, A. J., Weinberg, W. A., Kowatch, R. A., Hughes, C. W., Carmody, T., & Rintelmann, J. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54(11), 1031-1037. https://doi.org/10.1001/archpsyc.1997.01830230069010
Emslie, G. J., Ventura, D., Korotzer, A., & Tourkodimitris, S. (2009). Escitalopram in the treatment of adolescent depression: A randomized placebo-controlled multisite trial. Journal of American Academy of Child and Adolescent Psychiatry, 48(7), 721-729. https://doi.org/10.1097/CHI.0b013e3181a2b304
Emslie, G. J., Wagner, K. D., Kutcher, S., Krulewicz, S., Fong, R., Carpenter, D. J., Lipschitz, A., Machin, A., & Wilkinson, C. (2006). Paroxetine treatment in children and adolescents with major depressive disorder: A randomized, multicenter, double-blind, placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 45(6), 709-719. https://doi.org/10.1097/01.chi.0000214189.73240.63
Findling, R. L., Pagano, M. E., McNamara, N. K., Stansbrey, R. J., Faber, J. E., Lingler, J., & Reed, M. D. (2009). The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial. Child and Adolescent Psychiatryand Mental Health, 3(11), 1-13. https://doi.org/10.1186/1753-2000-3-11
Fleming, T., Dixon, R., Frampton, C., & Merry, S. (2012). A pragmatic randomized controlled trial of computerized CBT (SPARX) for symptoms of depression among adolescents excluded from mainstream education. Behavioural and Cognitive Psychotherapy, 40(5), 529-541.
Fortney, J. C., Unützer, J., Wrenn, G., Pyne, J. M., Smith, G. R., Schoenbaum, M., & Harbin, H. T. (2016). A tipping point for measurement-based care. Psychiatric Services, 68(14). https://doi.org/10.1176/appi.ps.201500439
Frank, E., Prien, R. F., Jarrett, R. B., Keller, M. B., Kupfer, D. J., Lavori, P. W., Rush, A. J., & Weissman, M. M. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence. Archives of General Psychiatry, 48(9), 851-855. https://doi.org/10.1001/archpsyc.1991.01810330075011
Frank, E., Prien, R. F., Jarrett, R. B., Keller, M. B., Kupfer, D. J., Lavori, P. W., & Weissman, M. M. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence. Archives of General Psychiatry, 48(9), 851-855. https://doi.org/10.1001/archpsyc.1991.01810330075011
Gabbay, V., Freed, R. D., Alonso, C. M., Senger, S., Stadterman, J., Davison, B. A., & Klein, R. G. (2018). A double-blind placebo-controlled trial of omega-3 fatty acids as a monotherapy for adolescent depression. The Journal of Clinical Psychiatry, 79(4). https://doi.org/10.4088/JCP.17m11596
Geller, B., Cooper, T. B., Graham, D. L., Marsteller, F. A., & Bryant, D. M. (1990). Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a “‘fixed plasma level'” design. Psychopharmacology Bulletin, 26(1), 85-90.
Goodyer, I. M., Reynolds, S., Barrett, B., Byford, S., Dubicka, B., Hill, J., & Roberts, C. (2017). Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): A multicentre, pragmatic, observer-blind, randomised controlled trial. Health Technology Assessment, 21(12), 1-94. https://doi.org/10.3310/hta21120
Gore, F. M., Bloem, P. J. N., Patton, G. C., Ferguson, J., Joseph, V., Coffey, C., & Mathers, C. D. (2011). Global burden of disease in young people aged 10-24 years: A systematic analysis. The Lancet, 377(9783), 2093-2102. https://doi.org/10.1016/S0140-6736(11)60512-6
Gunlicks-stoessel, M., Mufson, L., Bernstein, G., Westervelt, A., Reigstad, K., Klimes-dougan, B., Cullen, K., Murray, A., & Vock, D. (2019). Critical decision points for augmenting interpersonal sequential multiple assignment randomized trial. Journal of the American Academy of Child & Adolescent Psychiatry, 58(1), 80-91. https://doi.org/10.1016/j.jaac.2018.06.032
Guy, W. (1976). ECDEU assessment manual for psychopharmacology. US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs.
Haltigan, J. D., Aitken, M., Skilling, T., Henderson, J., Hawke, L., Battaglia, M., & Andrade, B. F. (2018). “P” and “DP:” Examining symptom-level bifactor models of psychopathology and dysregulation in clinically referred children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 57(6), 384-396. https://doi.org/10.1016/j.jaac.2018.03.010
Hayes, L., Boyd, C. P., & Sewell, J. (2011). Acceptance and commitment therapy for the treatment of adolescent depression: A pilot study in a psychiatric outpatient setting. Mindfulness, 2(2), 86-94. https://doi.org/10.1007/s12671-011-0046-5
Hughes, C. W., Barnes, S., Barnes, C., Defina, L. F., Nakonezny, P., & Emslie, G. J. (2013). Depressed adolescents treated with exercise (DATE): A pilot randomized controlled trial to test feasibility and establish preliminary effect sizes. Mental Health and Physical Activity, 6(2), 119-131. https://doi.org/10.1016/j.mhpa.2013.06.006
Heiligenstein, J. H., Hoog, S. L., Wagner, K. D., Findling, R. L., Galil, N., Kaplan, S., Busner, J., Nilsson, M. E., Brown, E. B., & Jacobson, J. G. (2006). Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: A pilot study. Journal of Child & Adolescent Psychopharmacology, 16(1-2), 207-217. https://doi.org/10.1089/cap.2006.16.207
Iftene, F., Predescu, E., Stefan, S., & David, D. (2015). Rational-emotive and cognitive-behavior therapy (REBT/CBT) versus pharmacotherapy versus REBT/CBT plus pharmacotherapy in the treatment of major depressive disorder in youth: A randomized clinical trial. Psychiatry Research, 225(3), 687-694. https://doi.org/10.1016/j.psychres.2014.11.021
Israel, P., & Diamond, G. S. (2013). Feasibility of attachment based family therapy for depressed clinic-referred Norwegian adolescents. Clinical Child Psychology &. Psychiatry, 18(3), 334-350. https://doi.org/10.1177/1359104512455811
Jacobson, N. S., Roberts, L. J., Berns, S. B., & McGlinchey, J. B. (1999). Methods for defining and determining the clincial signifance of treatment effects: Description, application, and alternates. Journal of Consulting and Clinical Psychology, 67(3), 300-307.
Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59(1), 12-19.
Keller, M. B., Ryan, N. D., Strober, M., Klein, R. G., Kutcher, S. P., Birmaher, B., & McCafferty, J. P. (2001). Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry, 40(7), 762-772.
Kelly, L. E., Shan, F., MacVicar, S., Czaplinksi, E., Moulsdale, W., Simpson, S., & Offringa, M. (2020). A core outcome set for neonatal opioid withdrawal syndrome. Pediatrics, 146(1).
Kennard, B., Silva, S., Vitiello, B., Curry, J., Kratochvil, C., & Simons, A., TADSTeam. (2006). Remission and residual symptoms after short-term treatment in the treatment of adolescents with depression study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry, 45(12), 1404-1411. https://doi.org/10.1097/01.chi.0000242228.75516.21
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., & Blier, P., CANMAT Depression Work Group. (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological treatments. The Canadian Journal of Psychiatry, 61(9), 540-560.
Klein, R. G., Mannuzza, S., Koplewicz, H. S., Tancer, N. K., Shah, M., Liang, V., & Davies, M. (1998). Adolescent depression: Controlled desipramine treatment and atypical features. Depression and Anxiety, 7(1), 15-31. https://doi.org/10.1002/(sici)1520-6394(1998)7:1%3C15::aid-da3%3E3.0.co;2-4
Knaapen, M., Hall, N. J., Moulin, D., van der Lee, J. H., Butcher, N. J., Minneci, P. C., & Gorter, R. R. (2020). International core outcome set for acute simple appendicitis in children: Results of a systematic review, Delphi study, and focus groups with young people. Annals of Surgery
Von Knorring, A. L., Olsson, G. I., Thomsen, P. H., Lemming, O. M., & Hultén, A. (2006). A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. Journal of Clinical Psychopharmacology, 26(3), 311-315.
Kramer, A. D., & Feiguine, R. J. (1981). Clinical effects of amitriptyline in adolescent depression. A pilot study. Journal of the American Academy of Child Psychiatry, 20(3), 636-644. https://doi.org/10.1016/s0002-7138(09)6150-2
Krause, K. R., Bear, H. A., Edbrooke-Childs, J., & Wolpert, M. (2019). Review: What outcomes count? A review of outcomes measured for adolescent depression between 2007 and 2017. Journal of the American Academy of Child and Adolescent Psychiatry, 58(1), 61-71. https://doi.org/10.1016/j.jaac.2018.07.893
March, J., Silva, S., Petrycki, S., Curry, J., Wells, K., Fairbank, J., & Severe, J. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for adolescents with depression study (TADS) randomized controlled trial. JAMA: Journal of the American Medical Association, 292(7), 807-820. https://doi.org/10.1001/jama.292.7.807
Martinez, V., Rojas, G., Martinez, P., Gaete, J., Zitko, P., Vohringer, P. A., & Araya, R. (2019). Computer-assisted cognitive-behavioral therapy to treat adolescents with depression in primary health care centers in Santiago, Chile: A randomized controlled trial. Frontiers in Psychiatry, 10, 552. https://doi.org/10.3389/fpsyt.2019.00552
Mayo-Wilson, E., Fusco, N., Li, T., Dickersin, K., Hong, H., & Canner, J. K. (2017). Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis. Journal of Clinical Epidemiology, 86, 39-50. https://doi.org/10.1016/j.jclinepi.2017.05.007
McCauley, E., Gudmundsen, G., Schloredt, K., Martell, C., Rhew, I., Hubley, S., & Dimidjian, S. (2016). The adolescent behavioral activation program: Adapting behavioral activation as a treatment for depression in adolescence. Journal of Clinical Child and Adolescent Psychology, 45(3), 291-304. https://doi.org/10.1080/15374416.2014.979933
Melvin, G. A., Tonge, B. J., King, N. J., Heyne, D., Gordon, M. S., & Klimkeit, E. (2006). A comparison of cognitive-behavioral therapy, sertraline, and their combination for adolescent depression. Journal of the American Academy of Child and Adolescent Psychiatry, 45(10), 1151-1161. https://doi.org/10.1097/01.chi.0000233157.21925.71
Merry, S. N., Stasiak, K., Shepherd, M., Frampton, C., Fleming, T., Mathijs, F., & Lucassen, M. F. G. (2012). The effectiveness of SPARX, a computerised self help intervention for adolescents seeking help for depression: randomised controlled non-inferiority trial. BMJ: British Medical Journal, 344(7857), 16. https://doi.org/10.1136/bmj.e2598
Mew, E. J., Monsour, A., Saeed, L., Santos, L., Patel, S., Courtney, D. B., & Monga, S. (2020). Systematic scoping review identifies heterogeneity in outcomes measured in adolescent depression clinicaltrials. Journal of Clinical Epidemiology, 126, 71-79. https://doi.org/10.1016/j.jclinepi.2020.06.013
Mojtabai, R., Olfson, M., & Han, B. (2016). National trends in the prevalence and treatment of depression in adolescents and young adults. Pediatrics, 138(6). https://doi.org/10.1542/peds.2016-1878
Monga, S., Monsour, A., Stallwood, E., Desai, R., Cleverley, K., Courtney, D., & Smith, M. (2020). Core outcome set development for adolescent major depressive disorder clinical trials: A registered report. Journal of the American Academy of Child & Adolescent Psychiatry, 59, 1297-1298. https://doi.org/10.1016/j.jaac.2020.07.905
Monga, S., Offringa, M., Butcher, N. J., & Szatmari, P. (2020). From research to practice: The importance of appropriate outcome selection, measurement, and reporting in pediatric mental health research. Journal of the American Academy of Child and Adolescent Psychiatry, 59(4), 497-500. https://doi.org/10.1016/j.jaac.2019.08.468
Monsour, A., Mew, E. J., Patel, S., Chee-A-Tow, A., Saeed, L., Santos, L., & Butcher, N. J. (2020). Primary outcome reporting in adolescent depression clinical trials needs standardization. BMC Medical Research Methodology, 20(1), 1-15. https://doi.org/10.1186/s12874-020-01019-6
Parhiala, P., Ranta, K., Gergov, V., Kontunen, J., Law, R., La Greca, A. M., Torppa, M., & Marttunen, M. (2019). Interpersonal counseling in the treatment of adolescent depression: A randomized controlled effectiveness and feasibility study in school health and welfare services. School Mental Health, 12, 265-283.
Peters, M., Godfrey, C., McInerney, P., Munn, Z., Trico, A., & Khalil, H. (2020). JBI Manual for Evidence Synthesis. In (Eds.) Aromataris, E. & Munn, Z., JBI Manual for Evidence Synthesis. JBI. https://doi.org/10.46658/JBIMES-20-12
Poole, L. A., Knight, T., Toumbourou, J. W., Lubman, D. I., Bertino, M. D., & Lewis, A. J. (2018). A randomized controlled trial of the impact of a family-based adolescent depression intervention on both youth and parent mental health outcomes. Journal of Abnormal Child Psychology, 46(1), 169-181. https://doi.org/10.1007/s10802-017-0292-7
Poznanski, E. O., Freeman, L. N., & Mokros, H. B. (1985). Children's depression rating scale, revised. Psychopharmacol Bull, 21, 979-989. http://www.scalesandmeasures.net/files/files/Childrens%20Depression%20Rating%20Scale%20(1984).pdf
Prien, R. F., Carpenter, L. L., & Kupfer, D. J. (1991). The definition and operational criteria for treatment outcome of major depressive disorder: A review of the current research literature. Archives of General Psychiatry, 48(9), 796-800. https://doi.org/10.1001/archpsyc.1991.01810330020003
Renaud, J., Berlim, M. T., McGirr, A., Tousignant, M., & Turecki, G. (2008). Current psychiatric morbidity, aggression/impulsivity, and personality dimensions in child and adolescent suicide: A case-control study. Journal of Affective Disorders, 105(1-3), 221-228. https://doi.org/10.1016/j.jad.2007.05.013
Richardson, L. P., Ludman, E., McCauley, E., Lindenbaum, J., Larison, C., Zhou, C., Clarke, G., Brent, D., & Katon, W. (2014). Collaborative care for adolescents with depression in primary care: A randomized clinical trial. JAMA - Journal of the American Medical Association, 312(8), 809-816. https://doi.org/10.1001/jama.2014.9259
Rossello, J., & Bernal, G. (1999). The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. Journal of Consulting and Clinical Psychology, 67(5), 734-745. https://doi.org/10.1037/0022-006X.67.5.734
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., & Schatzberg, A. F. (2006). Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology, 31(9), 1841-1853.
Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61(2), 102-109. https://doi.org/10.1016/j.jclinepi.2007.03.012
Sackett, D. L., Rosenberg, W. M. C., Gray, J.aM., Haynes, R. B., & Richardson, W. S. (1996). Evidence based medicine: What it is and what it isn't. British Medical Journal, 312(7023), 71-72. https://doi.org/10.1136/bmj.312.7023.71
Sallee, F. R., Vrindavanam, N. S., Deas-Nesmith, D., Carson, S. W., & Sethuraman, G. (1997). Pulse intravenous clomipramine for depressed adolescents: Double- blind, controlled trial. American Journal of Psychiatry, 154(5), 668-673. https://doi.org/10.1176/ajp.154.5.668
Sanford, M., Boyle, M., McCleary, L., Miller, J., Steele, M., Duku, E., & Offord, D. (2006). A pilot study of adjunctive family psychoeducation in adolescent major depression: Feasibility and treatment effect. Journal of the American Academy of Child and Adolescent Psychiatry, 45(4), 386-395. https://doi.org/10.1097/01.chi.0000198595.68820.10
Shirk, S. R., DePrince, A. P., Crisostomo, P. S., & Labus, J. (2014). Cognitive behavioral therapy for depressed adolescents exposed to interpersonal trauma: An initial effectiveness trial. Psychotherapy, 51(1), 167-179. https://doi.org/10.1037/a0034845
Simeon, J. G., Dinicola, V. F., Ferguson, H. B., & Copping, W. (1990). Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-up. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 14(5), 790-795. https://doi.org/10.1016/0278-5846(90)90050-q
Sinha, I., Jones, L., Smyth, R. L., & Williamson, P. R. (2008). A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Medicine, 5(4), 569-578. https://doi.org/10.1371/journal.pmed.0050096
Stallwood, E., Monsour, A., Rodrigues, C., Monga, S., Terwee, C. B., Offringa, M., & Butcher, N. J. (2020). Systematic review: The measurement properties of the children's depression rating scale-revised (CDRS-R) for adolescents with major depressive disorder. Journal of American Academy of Child and Adolescent Psychiatry, 60, 119-133.
Stasiak, K., Hatcher, S., Frampton, C., & Merry, S. N. (2014). A pilot double blind randomized placebo controlled trial of a prototype computer-based cognitive behavioural therapy program for adolescents with symptoms of depression. Behavioural and Cognitive Psychotherapy, 42(4), 385-401. https://doi.org/10.1017/S1352465812001087
Tao, R., Emslie, G., Mayes, T., Nakonezny, P., Kennard, B., & Hughes, C. (2009). Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 48(1), 71-78. https://doi.org/10.1097/CHI.0b013e318190043e
The Lancet Psychiatry. (2020). Measuring success: the problem with primary outcomes. The Lancet Psychiatry, 7(1), 1. https://doi.org/10.1016/S2215-0366(19)30483-3
Topooco, N., Berg, M., Johansson, S., Liljethorn, L., Radvogin, E., Vlaescu, G., Nordgren, L. B., Zetterqvist, M., & Andersson, G. (2018). Chat- and internet-based cognitive-behavioural therapy in treatment of adolescent depression: Randomised controlled trial. British Journal of Psychiatry, 4(4), 199-207. https://doi.org/10.1192/bjo.2018.18
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., & Hempel, S. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467-473. https://doi.org/10.73216/M18-0850
De Vet, H. C., Terwee, C. B., Mokkink, L. B., & Knol, D. L. (2011). Measurement in medicine: Practical guide. Cambridge University Press.
Wagner, K. D., Jonas, J., Findling, R. L., Ventura, D., & Saikali, K. (2006). A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. Journal of the American Academy of Child & Adolescent Psychiatry, 45(3), 280-288. https://doi.org/10.1097/01.chi.0000192250.38400.9e
Wagner, K., D., Ambrosini, P., Rynn, M., Wohlberg, C., Yang, R., Greenbaum, M. S., Childress, A., Donnelly, C., Deas, & D. (2003). Efficacy of Sertraline in the Treatment of Children and Adolescents. The Journal of the American Medical Association, 290(8), 1033-1041.
Weihs, K. L., Murphy, W., Abbas, R., Chiles, D., England, R. D., Ramaker, S., & Wajsbrot, D. B. (2018). Desvenlafaxine versus placebo in a fluoxetine-referenced study of children and adolescents with major depressive disorder. Journal of Child and Adolescent Psychopharmacology, 28(1), 36-46. https://doi.org/10.1089/cap.2017.0100
Wunram, H. L., Hamacher, S., Hellmich, M., Volk, M., Janicke, F., Reinhard, F., Bloch, W., Zimmer, P., Graf, C., Schönau, E., Lehmkuhl, G., Bender, S., & Fricke, O. (2017). Whole body vibration added to treatment as usual is effective in adolescents with depression: A partly randomized, three-armed clinical trial in inpatients. European Child and Adolescent Psychiatry, 1-18. https://doi.org/10.1007/s00787-017-1071-2
Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011). The ClinicalTrials.gov results database - Update and key issues. New England Journal of Medicine, 364(9), 852-860. https://doi.org/10.1056/NEJMsa1012065
Zimmerman, M., McGlinchey, J. B., Posternak, M. A., Friedman, M., Boerescu, D., & Attiullah, N. (2008). Remission in depressed outpatients: More than just symptom resolution? Journal of Psychiatric Research, 42(10), 797-801. https://doi.org/10.1016/j.jpsychires.2007.09.004